Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Cannom

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Circulation|June 15, 2007
Uncertainty on the use of aldosterone antagonists for primary therapy for sudden cardiac death in the setting of implanted devicesRobert A Kloner, David S Cannom
Journal of the American College of Cardiology|May 5, 2022
Cardiac Arrest and Sudden Death: Establishing the Need for Focusing on Prehospital and In-Hospital CareDavid G Benditt, David S Cannom
Cardiac Electrophysiology Review|May 27, 2003
New device indications: impact on the individual electrophysiology (EP) practitioner in a predominantly managed care environmentMary Rose Patejak, David S Cannom
Heart Rhythm|April 11, 2013
The evolution of the implantable cardioverter defibrillatorDavid S Cannom, Eric N Prystowsky
Pacing and Clinical Electrophysiology : PACE|March 11, 2004
The evolution of the implantable cardioverter defibrillatorDavid S Cannom, Eric N Prystowsky
Journal of Cardiovascular Electrophysiology|March 20, 2004
Evolution of the implantable cardioverter defibrillatorDavid S Cannom, Eric N Prystowsky
Heartrhythm Case Reports|December 25, 2018
Is it bradycardia or something else causing symptoms?Brian Olshansky, Suzy Feigofsky, David S Cannom
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 2, 2005
Antiarrhythmic drugs in patients with implantable cardioverter-defibrillatorsAndreas Bollmann, Daniela Husser, David S Cannom
Journal of Cardiovascular Electrophysiology|April 15, 2018
ARTHUR J. MOSS MDSeah Nisam, David S Cannom, Wojciech Zareba
The American Journal of Medicine|October 12, 2010
Management of atrial fibrillation: translating clinical trial data into clinical practiceKim A Eagle, David S Cannom, David A Garcia
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Circulation|June 15, 2007
Uncertainty on the use of aldosterone antagonists for primary therapy for sudden cardiac death in the setting of implanted devicesRobert A Kloner, David S Cannom
Journal of the American College of Cardiology|May 5, 2022
Cardiac Arrest and Sudden Death: Establishing the Need for Focusing on Prehospital and In-Hospital CareDavid G Benditt, David S Cannom
Cardiac Electrophysiology Review|May 27, 2003
New device indications: impact on the individual electrophysiology (EP) practitioner in a predominantly managed care environmentMary Rose Patejak, David S Cannom
Heart Rhythm|April 11, 2013
The evolution of the implantable cardioverter defibrillatorDavid S Cannom, Eric N Prystowsky
Pacing and Clinical Electrophysiology : PACE|March 11, 2004
The evolution of the implantable cardioverter defibrillatorDavid S Cannom, Eric N Prystowsky
Journal of Cardiovascular Electrophysiology|March 20, 2004
Evolution of the implantable cardioverter defibrillatorDavid S Cannom, Eric N Prystowsky
Heartrhythm Case Reports|December 25, 2018
Is it bradycardia or something else causing symptoms?Brian Olshansky, Suzy Feigofsky, David S Cannom
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 2, 2005
Antiarrhythmic drugs in patients with implantable cardioverter-defibrillatorsAndreas Bollmann, Daniela Husser, David S Cannom
Journal of Cardiovascular Electrophysiology|April 15, 2018
ARTHUR J. MOSS MDSeah Nisam, David S Cannom, Wojciech Zareba
The American Journal of Medicine|October 12, 2010
Management of atrial fibrillation: translating clinical trial data into clinical practiceKim A Eagle, David S Cannom, David A Garcia
Pageof 7